• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.

作者信息

Ashby J, Brady A, Elcombe C R, Elliott B M, Ishmael J, Odum J, Tugwood J D, Kettle S, Purchase I F

机构信息

Zeneca Ltd, Central Toxicology Laboratory, Macclesfield, Cheshire, UK.

出版信息

Hum Exp Toxicol. 1994 Nov;13 Suppl 2:S1-117. doi: 10.1177/096032719401300201.

DOI:10.1177/096032719401300201
PMID:7857698
Abstract

In this review we have evaluated the relationship between peroxisome proliferation and hepatocarcinogenesis. To do so, we identified all chemicals known to produce peroxisome proliferation and selected those for which there are data (on peroxisome proliferation and hepatocarcinogenesis) which meet certain criteria chosen to facilitate comparison of these phenomena. The summarised data and definition of the methodology used has been collected in appendices. These comparisons enabled us to evaluate the relationship between these phenomena using reliable data. As there is a good correlation between them, we further explored the mechanisms of action that have been proposed (direct genotoxic activity, production of hydrogen peroxide, cell proliferation and receptor activation). The relationship between these events in other species, including humans, was also reviewed and finally an overview of the assessment of human hazard is presented in section IX. Some of the first chemicals which were shown to produce peroxisome proliferation were also hepatocarcinogens whose carcinogenicity could not be readily explained by genotoxic activity. This raised the suggestion that the unusual phenomenon of peroxisome proliferation was intricately linked to the carcinogenic activity of these agents. Three questions have exercised the attention of regulatory, industrial and academic toxicology since then; are chemicals which elicit peroxisome proliferation in the liver actually a coherent class of chemical carcinogens?; does the early biological phenomenon of peroxisome proliferation have real predictive value for and mechanistic association with rodent carcinogenesis?; and what hazard/risk do these agents pose to humans that may be exposed to them? Whether peroxisome proliferators are indeed a discrete class of rodent carcinogens would appear to be the single, most important question. If so, then the assumptions and procedures relevant to human hazard and risk assessment should be applied to the class and should be essentially generic; if not, each chemical should be considered independently. Our critical analysis of the published data for over 70 agents which have been shown to possess intrinsic ability to induce peroxisome proliferation in the livers of rodents has led to the conclusion that there exists a strong correlation between peroxisome proliferation as n early effect in the liver and hepatocarcinogenicity in chronic exposure studies. An almost perfect correlation was observed between the induction of peroxisomes in the rodent liver and the eventual appearance of tumours following chronic exposure The few exceptions to this were largely explainable (section II).(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

相似文献

1
Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Hum Exp Toxicol. 1994 Nov;13 Suppl 2:S1-117. doi: 10.1177/096032719401300201.
2
Hepatic peroxisome proliferation in rodents and its significance for humans.啮齿动物肝脏中的过氧化物酶体增殖及其对人类的意义。
Food Chem Toxicol. 1993 Nov;31(11):857-907. doi: 10.1016/0278-6915(93)90225-n.
3
Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals.过氧化物酶体增殖剂类药物和化学物质的肝癌致癌机制。
Annu Rev Pharmacol Toxicol. 1995;35:483-507. doi: 10.1146/annurev.pa.35.040195.002411.
4
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?过氧化物酶体增殖化合物对人类有致癌风险吗?
Regul Toxicol Pharmacol. 1998 Feb;27(1 Pt 1):47-60.
5
[Proliferation of peroxisomes and the hepatocarcinogenic process].[过氧化物酶体增殖与肝癌致癌过程]
Rocz Panstw Zakl Hig. 1997;48(1):1-11.
6
Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).非遗传毒性致癌物对啮齿动物肝细胞生长控制的干扰:作用机制及与人类健康的不相关性(综述)
Oncol Rep. 1998 Nov-Dec;5(6):1319-27. doi: 10.3892/or.5.6.1319.
7
Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?过氧化物酶体增殖是邻苯二甲酸二(2-乙基己基)酯(DEHP)致癌性的一个必要前期步骤吗?
Environ Health Perspect. 2001 May;109(5):437-42. doi: 10.1289/ehp.01109437.
8
[Peroxisome proliferation and possible cancer hazard].
Tidsskr Nor Laegeforen. 1995 Jun 10;115(15):1839-41.
9
Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.过氧化物酶体酶的差异诱导与调控:过氧化物酶体增殖在识别某些非诱变致癌物中的预测价值。
Toxicol Appl Pharmacol. 1989 Jan;97(1):72-87. doi: 10.1016/0041-008x(89)90056-2.
10
Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.肝脏过氧化物酶体增殖剂致癌作用:降血脂药物和工业增塑剂对人类风险的评估
Crit Rev Toxicol. 1983;12(1):1-58. doi: 10.3109/10408448309029317.

引用本文的文献

1
Identifying novel mechanisms of per- and polyfluoroalkyl substance-induced hepatotoxicity using FRG humanized mice.利用 FRG 人源化小鼠鉴定全氟和多氟烷基物质诱导肝毒性的新机制。
Arch Toxicol. 2024 Sep;98(9):3063-3075. doi: 10.1007/s00204-024-03789-0. Epub 2024 May 23.
2
Kinetically-derived maximal dose (KMD) indicates lack of human carcinogenicity of ethylbenzene.动力学推导的最大剂量 (KMD) 表明乙基苯缺乏人类致癌性。
Arch Toxicol. 2024 Jan;98(1):327-334. doi: 10.1007/s00204-023-03629-7. Epub 2023 Dec 7.
3
Immunomodulation and exposure to per- and polyfluoroalkyl substances: an overview of the current evidence from animal and human studies.
免疫调节与全氟及多氟烷基物质暴露:动物和人体研究现有证据概述。
Arch Toxicol. 2022 Aug;96(8):2261-2285. doi: 10.1007/s00204-022-03303-4. Epub 2022 Jun 13.
4
(Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action.(芒果):一种用于乳腺癌治疗的有前景的药用植物及其潜在作用机制的研究
Breast Cancer (Dove Med Press). 2021 Sep 13;13:471-503. doi: 10.2147/BCTT.S316667. eCollection 2021.
5
Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.肠型过氧化物酶体增殖物激活受体 α 通过调控甲基转移酶 DNMT1 和 PRMT6 预防结肠癌发生。
Gastroenterology. 2019 Sep;157(3):744-759.e4. doi: 10.1053/j.gastro.2019.05.057. Epub 2019 May 30.
6
Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma.丙型肝炎病毒核心蛋白调节几种参与肝细胞癌的信号通路。
World J Gastroenterol. 2019 Jan 7;25(1):42-58. doi: 10.3748/wjg.v25.i1.42.
7
The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.PPARα 依赖性啮齿类动物肝脏肿瘤反应与人类无关:纠正误解。
Arch Toxicol. 2018 Jan;92(1):83-119. doi: 10.1007/s00204-017-2094-7. Epub 2017 Dec 2.
8
Redox Regulation of Homeostasis and Proteostasis in Peroxisomes.过氧化物酶体中稳态和蛋白质稳态的氧化还原调节
Physiol Rev. 2018 Jan 1;98(1):89-115. doi: 10.1152/physrev.00033.2016.
9
In vitro cytogenetic toxicity of bezafibrate in human peripheral blood lymphocytes.非诺贝特对人外周血淋巴细胞的体外细胞遗传毒性
Cytotechnology. 2017 Aug;69(4):579-589. doi: 10.1007/s10616-017-0069-4. Epub 2017 Jan 17.
10
The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes.过氧化物酶体增殖物激活受体α的截短剪接变体PPARα-tr可自主调节增殖基因和促炎基因。
BMC Cancer. 2015 Jun 30;15:488. doi: 10.1186/s12885-015-1500-x.